Biogenic pharma Stenabolic Biogenic pharma

Additional information Water Retention No significant water retention Hepatotoxicity Not enough data to determine Lab Test Specific tests for detection in blood or urine not widely detailed Also known as SR9009, Stenabolic Blood pressure No significant impact reported Trade name Not available under any trade name as it is not commercially marketed Storage conditions Store at room temperature away from moisture and light Chemical name Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate Formula C20H24ClN3O4S Substance class Synthetic drug, Rev-ErbA ligand Main action Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage Half-life Approximately 4-5 hours Dosage (medical) Not clinically approved for medical use Dosage (sports) Typically 10-40 mg per day Effects Increased endurance, reduced fat mass, increased wakefulness Side effects Potential alterations in circadian rhythms, limited data on long-term effects Use in sports Used as a performance-enhancing drug, not approved by WADA Manufacturer Biogenic pharma